Filing Details

Accession Number:
0001818382-24-000076
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-03 16:31:36
Reporting Period:
2024-06-03
Accepted Time:
2024-06-03 16:31:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1818382 Humacyte Inc. HUMA Biological Products, (No Disgnostic Substances) (2836) 851763759
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1878075 E Laura Niklason 2525 East North Carolina Highway 54
Durham NC 27713
President, Ceo And Director Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-03 2,050 $7.37 238,470 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,148,240 Indirect By The Niklason Living Trust
Common Stock 510,161 Indirect By spouse
Common Stock 6,191,140 Indirect By Ayabudge LLC
Footnotes
  1. Reflects a transfer of 1,148,240 shares of common stock by Laura E. Niklason to The Niklason Living Trust on April 19, 2024, which was exempt from reporting under Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.